Skip to main content
placeholder image

Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc)

Journal Article


Abstract


Publication Date


  • 2014

Citation


  • Yang, J. C., Kim, D., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M., . . . Janne, P. A. (2014). Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc). Annals of Oncology, 25, iv149. doi:10.1093/annonc/mdu331.9

Web Of Science Accession Number


Start Page


  • iv149

Volume


  • 25

Abstract


Publication Date


  • 2014

Citation


  • Yang, J. C., Kim, D., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M., . . . Janne, P. A. (2014). Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc). Annals of Oncology, 25, iv149. doi:10.1093/annonc/mdu331.9

Web Of Science Accession Number


Start Page


  • iv149

Volume


  • 25